» Articles » PMID: 27934801

Derivation & Validation of Glycosylated Haemoglobin (HbA ) Cut-off Value As a Diagnostic Test for Type 2 Diabetes in South Indian Population

Overview
Specialty General Medicine
Date 2016 Dec 10
PMID 27934801
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Objectives: Glycosylated haemoglobin (HbA 1c ) has been in use for more than a decade, as a diagnostic test for type 2 diabetes. Validity of HbA 1c needs to be established in the ethnic population in which it is intended to be used. The objective of this study was to derive and validate a HbA 1c cut-off value for the diagnosis of type 2 diabetes in the ethnic population of Rayalaseema area of south India.

Methods: In this cross-sectional study, consecutive patients suspected to have type 2 diabetes underwent fasting plasma glucose (FPG) and 2 h post-load plasma glucose (2 h-PG) measurements after a 75 g glucose load and HbA 1c estimation. They were classified as having diabetes as per the American Diabetes Association criteria [(FPG ≥7 mmol/l (≥126 mg/dl) and/or 2 h-PG ≥11.1 mmol/l (≥200 mg/dl)]. In the training data set (n = 342), optimum cut-off value of HbA 1c for defining type 2 diabetes was derived by receiver-operator characteristic (ROC) curve method using oral glucose tolerance test results as gold standard. This cut-off was validated in a validation data set (n = 341).

Results: On applying HbA 1c cut-off value of >6.3 per cent (45 mmol/mol) to the training data set,sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for diagnosing type 2 diabetes were calculated to be 90.6, 85.2, 80.8 and 93.0 per cent, respectively. When the same cut-off value was applied to the validation data set, sensitivity, specificity, PPV and NPV were 88.8 , 81.9, 74.0 and 92.7 per cent, respectively, although the latter were consistently smaller than the proportions for the training data set, the differences being not significant.

Interpretation & Conclusions: HbA 1c >6.3 per cent (45 mmol/mol) appears to be the optimal cut-off value for the diagnosis of type 2 diabetes applicable to the ethnic population of Rayalaseema area of Andhra Pradesh state in south India.

Citing Articles

Effect of Two-Only-Meal Frequency and Exercise on HbA1C Outcomes, Weight, and Anti-Diabetic Medication in Type 2 Diabetes in a Popular Lifestyle Change Campaign in Maharashtra, Compared to Conventional Clinical Management: A Quasi-Experimental....

Ashtekar S, Deshmukh P, Ghaisas N, Ashtekar C, Upasani S, Kirloskar M Indian J Community Med. 2023; 48(1):91-97.

PMID: 37082386 PMC: 10112759. DOI: 10.4103/ijcm.ijcm_248_22.


Intermediate hyperglycaemia and 10-year mortality in resource-constrained settings: the PERU MIGRANT Study.

Lazo-Porras M, Ruiz-Alejos A, Miranda J, Carrillo-Larco R, Gilman R, Smeeth L Diabet Med. 2020; 37(9):1519-1527.

PMID: 32181918 PMC: 7649719. DOI: 10.1111/dme.14298.


Comparison of Hemoglobin A with Fasting and 2-h Plasma Glucose Tests for Diagnosis of Diabetes and Prediabetes among High-risk South Indians.

Radhakrishna P, Vinod K, Sujiv A, Swaminathan R Indian J Endocrinol Metab. 2018; 22(1):50-56.

PMID: 29535937 PMC: 5838911. DOI: 10.4103/ijem.IJEM_254_17.


Authors' Response.

Mohan A, Aparna Reddy S, Sachan A, Sarma K, Kumar D, Panchagnula M Indian J Med Res. 2017; 145(4):573-574.

PMID: 28862195 PMC: 5663177. DOI: 10.4103/0971-5916.213767.


Choice of criterion used in the receiver operating characteristic analysis.

Habibzadeh F, Habibzadeh P, Yadollahie M Indian J Med Res. 2017; 145(4):571-572.

PMID: 28862194 PMC: 5663176. DOI: 10.4103/ijmr.IJMR_2002_16.

References
1.
BUNN H, Haney D, Kamin S, GABBAY K, Gallop P . The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. J Clin Invest. 1976; 57(6):1652-9. PMC: 436825. DOI: 10.1172/JCI108436. View

2.
Ravi Kumar P, Bhansali A, Ravikiran M, Bhansali S, Dutta P, Thakur J . Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. J Clin Endocrinol Metab. 2010; 95(6):2832-5. DOI: 10.1210/jc.2009-2433. View

3.
Perkins N, Schisterman E . The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006; 163(7):670-5. PMC: 1444894. DOI: 10.1093/aje/kwj063. View

4.
. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

5.
Nair M, Prabhakaran D, Narayan K, Sinha R, Lakshmy R, Devasenapathy N . HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians. Prim Care Diabetes. 2011; 5(2):95-102. PMC: 3117965. DOI: 10.1016/j.pcd.2011.02.002. View